SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

NCT04014101 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: SHR-1210
DRUG: apatinib

Sponsor

Shanghai Zhongshan Hospital